Begin with the End in Mind
Ophthalmic Product Development Insights
Aciex Enters Into Collaborative Research Agreement with Portola to Develop Dual Syk/JAK Inhibitors for Ophthalmic Indications
Ora will provide clinical development and regulatory consulting services to the collaboration.
The Drug Development Path
Business of retina clinical trials for the retina specialist
Nobel Therapeutics And Ophthalmology
How the subject of Nobel-Prize-winning, landmark scientific
research is making its way into our patients’ eyes.
Glaucoma Therapeutics 2013
A look at the safety and efficacy of various therapies for the disease, from pharmaceuticals to surgical implants.
Bausch + Lomb Licenses New Technology with Potential to Treat Millions Affected by Ocular Redness
May Offer Faster, More Effective, Longer Lasting Relief
Pre-clinical models
Ora’s pre-clinical group is busy developing a number of animal models of ocular disease to use in early stages of the development and candidate drug screening process.
Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy
The goal of this study was to assess the effect of a controlled adverse environment (CAE) challenge